Bajaj Healthcare Limited — Important, 05-04-2025: General Updates

Bajaj Healthcare Limited has announced a board meeting to discuss its successful acquisition of Genrx Pharmaceuticals Private Limited, now a going concern, for a cash consideration of ₹10.85 crores. This strategic acquisition aligns with Bajaj’s aim to expand its capabilities in the pharmaceutical sector, acquiring 100% control of Genrx. The transaction is expected to be completed within 3-6 months, pending necessary FDA approvals. This development may generate a positive outlook for Bajaj Healthcare, potentially boosting its market position and operational scope in the competitive pharmaceutical landscape.